U.S. to limit states’ access to COVID antibody treatments as demand rises … Aggressively reducing Alzheimer’s risk factors could mean 1.2 million fewer cases in 2050: experts … NIH launches nationwide...
Clinical briefs for Friday, March 12
By
Alicia Lasek
Mar 12, 2021
It’s time to appoint medical directors in assisted living, panel says … UK COVID variant 64% more deadly … Thousands of bottles of Lipitor generic pulled over impurity fears … Scientists detect...
Clinical briefs for Thursday, April 7
By
Amy Novotney
Apr 07, 2022
Virtual dementia care program leads to 60% reduction in hospital admissions: study … Biden Administration accelerates effort to prevent, detect and treat Long COVID … BA.2 now behind 72% of all US...
Clinical briefs for Monday, Aug. 9
By
Alicia Lasek
Aug 09, 2021
Feds weigh withholding Medicare funding for LTCFs that don’t mandate vaccines … Physicians report 20% increase in burnout, new survey finds … Treatment of tenacious stomach bug that troubles elderly...
Clinical briefs for Monday, Jan. 4
By
Alicia Lasek
Jan 04, 2021
New variant of COVID-19 reported in more U.S. states … COVID may cause chronic nervous system inflammation (POTS) … Novavax’s coronavirus vaccine heads to final-stage trial … Interpretation of...
Scientists predict new virus strain will worsen U.S. infection spike
By
Alicia Lasek
Jan 15, 2021
Scientists are raising concerns that new genetic strains of SARS-CoV-2 will spark renewed outbreaks in the United States at a time when cases are already spiking.
FDA: Viral mutations unlikely to cause false negatives in COVID-19 tests
By
Alicia Lasek
Jan 11, 2021
The agency has alerted healthcare providers that it is monitoring approved SARS-CoV-2 molecular tests to ensure that new viral mutations do not alter their accuracy.
Clinical briefs for Friday, May 14
By
Donna Shryer
May 14, 2021
More than a third of vaccinated older adults will continue wearing masks until at least 2022, study finds … New drug may prevent Alzheimer’s disease, early study suggests … COVID-19 lessons learned...
Bamlanivimab cuts risk of COVID in nursing homes and assisted living, study finds
By
Alicia Lasek
Jun 08, 2021
The investigation was conducted before the FDA revoked emergency use of the drug — a monoclonal antibody — due to the impact of genetic variants on efficacy. But it still can be used in combination...
Coronavirus reinfections in Kentucky nursing home worse second time around, officials say
By
Alicia Lasek
Feb 26, 2021
Five residents of a skilled nursing facility tested positive twice for SARS-CoV-2 in separate outbreaks three months apart, before vaccines were available. The disease course was more severe in the second...